Genetic Divergence and Antibody Expression Influence the N‐Glycomes of CHO‐K1 and CHO‐S Cells
Biotechnology and Bioengineering · 2025
DOI: 10.1002/bit.70045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2025. Verfasst von Roberto Donini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Polysaccharides, Genetic Variation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, R.D. thanks the U.K. Biotechnology and Biological Sciences Research Council (BBSRC) for their PhD studentship (BB/M011178/1). R.J.P. was funded by a Wellcome T….
Abstract (Originalsprache)
While Chinese hamster ovary (CHO) cells continue to be the workhorse of recombinant therapeutic protein production, decades of genetic divergence in the industrially relevant CHO‐K1 and CHO‐S cell lines, are likely to have resulted in differing glycosylation capabilities. Glycosylation can influence the efficacy, serum half‐life, and safety of biologics, and as a critical quality attribute of glycoprotein biopharmaceuticals, it is essential to better understand how major CHO cell manufacturing platforms diverge. We used matrix‐assisted laser desorption ionization‐time of flight mass spectrometry to perform N‐glycomic analyses comparing CHO‐K1 cells, CHO‐S cells and antibody‐producing daughter cell lines. The results reveal that genetic divergence in these industrially relevant cell lines, as well as the burden of antibody production, lead to significant differences in antennal branching and terminal elaboration in the cellular N‐glycome. More specifically, CHO‐K1 cells produce larger and more complex N‐glycans with higher levels of sialylation than CHO‐S cells, and antibody production was associated with increased antennal branching. Additionally, these findings were also reflected in the N‐glycomic profiles of IgG1‐Fc constructs produced in either CHO‐K1 and CHO‐S cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, Imperial College London, London, UK.
- Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
- Department of Chemical Engineering, Imperial College London, London, UK.
ORCID-Profile: Roberto Donini, Pat Blundell, Richard J Pleass, Anne Dell, Cleo Kontoravdi, Stuart M Haslam
Förderung
- Wellcome Trust
- R.D. thanks the U.K. Biotechnology and Biological Sciences Research Council (BBSRC) for their PhD studentship (BB/M011178/1). R.J.P. was funded by a Wellcome T…
Zitieren
APA
Donini, R., Blundell, P., Pleass, R. J., Lu, D., Dell, A., Kontoravdi, C., & Haslam, S. M. (2025). Genetic Divergence and Antibody Expression Influence the N‐Glycomes of CHO‐K1 and CHO‐S Cells. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70045
Vancouver
Donini R, Blundell P, Pleass RJ, Lu D, Dell A, Kontoravdi C, et al. Genetic Divergence and Antibody Expression Influence the N‐Glycomes of CHO‐K1 and CHO‐S Cells. Biotechnology and Bioengineering. 2025. doi:10.1002/bit.70045
BibTeX
@article{Donini2025,
author = {Donini, Roberto and Blundell, Pat and Pleass, Richard J and Lu, Dongli and Dell, Anne and Kontoravdi, Cleo and Haslam, Stuart M},
title = {Genetic Divergence and Antibody Expression Influence the N‐Glycomes of CHO‐K1 and CHO‐S Cells},
journal = {Biotechnology and Bioengineering},
year = {2025},
doi = {10.1002/bit.70045}
}
EUVIMED